BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastroenterol. Sep 14, 2025; 31(34): 111541
Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.111541
Table 4 Univariable and multivariable cox proportional hazards analyses for overall survival and recurrence-free survival
Variable
Overall survival
Recurrence-free survival
Univariable analysis
Multivariable analysis
Univariable analysis
Multivariable analysis
Signature from SR MRI1.67 (1.21, 2.30)0.0021.81 (1.29, 2.55)0.0011.39 (1.04, 1.88)0.0281.36 (1.02, 1.85)0.042
Age (> 65 years)1.20 (0.80, 1.79)0.3811.12 (0.79, 1.59)0.533
Gender (male)1.08 (0.70, 1.67)0.7231.13 (0.75, 1.71)0.559
HBV0.97 (0.67, 1.39)0.8550.93 (0.67, 1.29)0.677
Cirrhosis1.30 (0.94, 1.80)0.1181.15 (0.86, 1.54)0.341
MVI1.78 (1.28, 2.47)< 0.0011.48 (1.04, 2.09)0.0291.80 (1.34, 2.42)0.0011.67 (1.23, 2.28)0.001
INR (> 1.5 ratio)2.31 (0.32, 16.64)0.4052.61 (0.64, 10.54)0.179
AFP1.48 (1.02, 2.14)0.041.53 (1.06, 2.19)0.2191.44 (1.03, 2.02)0.031
Multiple1.07 (0.67, 1.72)0.7661.59 (1.07, 2.37)0.0211.53 (1.03, 2.28)0.036
Pseudocapsule0.74 (0.52, 1.04)0.0830.88 (0.65, 1.20)0.426
Tumor size1.38 (1.01, 1.90)0.0491.53 (1.06, 2.19)0.0221.38 (1.01, 1.91)0.0481.38 (0.96, 1.98)0.08


Write to the Help Desk